REDWOOD CITY, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will report third quarter financial results after the close of market on November 4, followed at 4:30 p.m. Eastern Time by a conference call and audio webcast at www.codexis.com.
| Live Call: | U.S.: 866-825-3209 |
| International: 617-213-8061 | |
| Passcode: 47125991 | |
| Live Webcast: | Codexis IR website |
| Replay: | U.S.: 888-286-8010 |
| International: 617-801-6888 | |
| Passcode: 94211534 | |
| Conference call replay will be available through Nov. 11 | |
| The webcast will be archived on the IR section of www.codexis.com for 30 days. |
About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis’ proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.
CONTACT: Investors Mike Rice, 646-597-6987 mrice@lifesciadvisors.com Media Jemma Connor, +44 161 359 3255 jemma.connor@notchcommunications.co.uk
Help employers find you! Check out all the jobs and post your resume.
